LBA16 KEYNOTE-355: Final results from a randomized, double-blind phase III study of first-line pembrolizumab + chemotherapy vs placebo + chemotherapy for metastatic TNBC

Authors:
  • JCJ. Cortés
    J. Cortés
  • DCD.W. Cescon
    D.W. Cescon
  • HRH.S. Rugo
    H.S. Rugo
  • SIS-A. Im
    S-A. Im
  • MYM. Md Yusof
    M. Md Yusof
  • CGC. Gallardo
    C. Gallardo
  • OLO. Lipatov
    O. Lipatov
  • CBC.H. Barrios
    C.H. Barrios
  • JPJ. Perez-Garcia
    J. Perez-Garcia
  • HIH. Iwata
    H. Iwata
  • NMN. Masuda
    N. Masuda
  • MOM. Torregroza Otero
    M. Torregroza Otero

Abstract
No abstract available